EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the...
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA...
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre...
Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc. PR Newswire NEW YORK, Feb. 16, 2024 NEW YORK, Feb. 16...
Kuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 16...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.